Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 92
1.
Farmaco ; 59(10): 793-801, 2004 Oct.
Article En | MEDLINE | ID: mdl-15474056

The disposition of the furocoumarin 4,6,4'-trimethylangelicin (4,6,4'-TMA) was studied in mice. After oral administration of (3)H 4,6,4'-TMA, radioactivity measured in serum shows fast absorption and slow elimination. Serum protein binding is higher as compared to 8-methoxypsoralen (8-MOP), currently used in photochemotherapy (PUVA) and linearly declines from 30 min to 6 h after administration. Distribution in the various organs was similar to that of 8-MOP and was relatively uninfluenced by UVA radiation, required for the biological effects of 4,6,4'-TMA. Mice eliminate (3)H 4,6,4'-TMA mostly through the urine, but also through the faeces. Two metabolites were identified in the urine and serum of the treated mice, one of which proved to be a derivative of 4,6,4'-TMA, formed by hydrogenation of the double 4',5' bond of the furocoumarin nucleus.


Furocoumarins/pharmacokinetics , PUVA Therapy , Animals , Darkness , Mice , Protein Binding , Tissue Distribution , Ultraviolet Rays
2.
J Inorg Biochem ; 83(1): 31-40, 2001 Jan 01.
Article En | MEDLINE | ID: mdl-11192697

The [M(ESDT)Cl]n (M = Pd or Pt; ESDT = EtO2CCH2(CH3)NCS2, methylamino-acetic acid ethyl ester-dithiocarboxylate) species have been reacted with various amines (py, pyridine; PrNH2, n-propylamine; c-BuNH2, cyclobutylamine; en, ethylenediamine) in dichloromethane or chloroform with the aim to obtain mixed ligand complexes. The neutral complexes [M(ESDT)(L)Cl] (L = py, PrNH2 or c-BuNH2) and the ionic species ([M(ESDT)(L)2]Cl and [M(ESDT)(En)]Cl) have been isolated, and characterized by IR and proton NMR spectroscopies. The crystal structure of [Pd(ESDT)(PrNH2)Cl] has been determined by X-ray crystallography. The behaviour of the complexes in various solvents was described on the basis of the proton NMR spectra. The complexes and the dithiocarbamato intermediates have been tested for in vitro cytostatic activity against human leukemic HL-60 and HeLa cells.


Amines/chemistry , Antineoplastic Agents/chemistry , Organometallic Compounds/chemistry , Palladium/chemistry , Platinum/chemistry , Thiocarbamates/chemistry , Amines/pharmacology , Antineoplastic Agents/pharmacology , Crystallography, X-Ray , Drug Screening Assays, Antitumor , HL-60 Cells , HeLa Cells , Humans , Magnetic Resonance Spectroscopy , Molecular Structure , Organometallic Compounds/pharmacology , Palladium/pharmacology , Platinum/pharmacology , Spectroscopy, Fourier Transform Infrared , Thiocarbamates/pharmacology
3.
Eur J Med Chem ; 35(9): 827-37, 2000 Sep.
Article En | MEDLINE | ID: mdl-11006484

A group of 9-substituted acridine and azacridine derivatives (m-AMSA analogues) were synthesised following classical procedures as potential antitumour agents with inhibitory effects on DNA topoisomerase II. Some were found to have noticeable cytotoxicity against human HL-60 and HeLa cells grown in culture. Their non-covalent interactions with calf thymus DNA have been studied using fluorescence quenching. We evaluated DNA damage produced by the tested compounds by means of DNA filter elution and protein precipitation techniques. Catalytic studies carried out with purified topoisomerase confirmed these agents as antitopoisomerase inhibitors. Chemotherapy of solid-tumour-bearing mice with tested compounds allowed an aza-analogue (compound IIIb), as potent as m-AMSA but less toxic towards the host, to be recognised.


Acridines/chemistry , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/pharmacology , Aza Compounds/chemical synthesis , Aza Compounds/pharmacology , Amsacrine/chemistry , Amsacrine/pharmacology , Animals , Aza Compounds/metabolism , Carcinoma, Ehrlich Tumor/drug therapy , Cell Division/drug effects , DNA/drug effects , DNA/metabolism , DNA Damage/drug effects , Drug Screening Assays, Antitumor , Enzyme Inhibitors/chemical synthesis , Enzyme Inhibitors/metabolism , Enzyme Inhibitors/pharmacology , HL-60 Cells/drug effects , HeLa Cells/drug effects , Humans , Inhibitory Concentration 50 , Mice , Structure-Activity Relationship , Topoisomerase II Inhibitors
4.
Photochem Photobiol ; 71(3): 254-62, 2000 Mar.
Article En | MEDLINE | ID: mdl-10732442

Some photochemical and photobiological properties of 4,6,8,9-tetramethyl-2H-furo[2,3-h]quinolin-2-one (HFQ) were studied in comparison with its isomer 1,4,6,8-tetramethyl-2H-furo[2,3-h]quinolin-2-one (FQ) and 8-methoxypsoralen (8-MOP). The HFQ photobinds to DNA forming furan-side monoadducts (MAHFQ) that have molecular structure very similar to those of FQ (MAFQ). Unlike MA8-MOP and MAFQ, MAHFQ no longer photoreact. The HFQ, like FQ, produces moderate amounts of singlet oxygen but no superoxide anions. The HFQ and FQ induce numbers of DNA-protein cross-links (DPC), much more plentiful than those of 8-MOP (about two and seven times, respectively) but no interstrand cross-links. The mechanism of DPC formation was studied in vivo in mammalian cells by alkaline elution and in vitro using a new test mixing histones and DNA from calf thymus. The latter is a very useful technique for the double irradiation protocol. The DNA (or histones) are separately exposed to a first UVA dose in the presence of the sensitizer; then, after its unbound molecules have been removed, histones (or DNA) are added to assemble the chromatin-like complex that is irradiated again. According to in vitro and in vivo methods, DPC appear to be formed by FQ and 8-MOP by a biphotonic process that starts with monoadduct induction in DNA, followed by their conversion into DPC. In the resulting lesions, the sensitizer molecule forms a covalent bridge between the two macromolecules (DPC at length greater than zero). Instead, HFQ induces DPC by a monophotonic process; thus, HFQ is probably not a physical part of the bridge between DNA and proteins, which may be linked together directly, like DPC at zero length induced by UVC.


DNA Damage , Photosensitizing Agents/toxicity , Quinolones/toxicity , Animals , Cattle , In Vitro Techniques , Methoxsalen/toxicity , Photochemistry , Reactive Oxygen Species , Ultraviolet Rays/adverse effects
5.
Photochem Photobiol ; 71(3): 263-72, 2000 Mar.
Article En | MEDLINE | ID: mdl-10732443

4,6,8,9-Tetramethyl-2H-furo[2,3-h]quinolin-2-one (HFQ) and its isomer FQ (1,4,6,8-tetramethyl-2H-furo[2,3-h]quinolin-2-one) showed very strong antiproliferative activity in mammalian cells, about two times greater than 8-methoxypsoralen (8-MOP). Both compounds induced DNA-protein cross-links (DPC) but not interstrand cross-links. The FQ generated DPC in a biphotonic process, yielding a new kind of diadduct, whereas HFQ induced DPC by a monophotonic one, probably without its physical participation in the covalent bridge. These lesions gave different toxic responses. Sensitization of FQ led to extensive DNA fragmentation and to a number of chromosomal aberrations. Conversely, HFQ seemed to be completely inactive and 8-MOP gave intermediate results. A strict relationship between DPC formation and induction of chromosomal aberrations was observed. The HFQ did not induce light skin erythemas, whereas FQ was more phototoxic than 8-MOP, thus suggesting that FQ lesions, DPC in particular, may be implicated in skin phototoxicity. Ehrlich ascites cells, a transplantable mouse tumor, inactivated by furoquinolinone sensitization and injected into healthy mice, protected them from a successive challenge by viable tumor cells. This response appeared to be based on an immune mechanism. Comparable amounts of base substitution revertants were scored when testing furoquinolinones and 8-MOP in bacteria but no DPC were detected. This suggests that classic mutagenesis tests on bacteria are insufficient to give adequate information on furocoumarin genotoxicity. Given its features, HFQ can be regarded as an interesting new agent for psoralen plus UVA photochemotherapy and photopheresis.


DNA Damage , Photosensitizing Agents/toxicity , Quinolones/toxicity , Animals , CHO Cells , Carcinoma, Ehrlich Tumor/drug therapy , Cricetinae , DNA Fragmentation/drug effects , DNA Fragmentation/radiation effects , Humans , Mice , PUVA Therapy , Photobiology , Skin/radiation effects , Ultraviolet Rays/adverse effects
6.
Farmaco ; 55(9-10): 650-8, 2000.
Article En | MEDLINE | ID: mdl-11152248

A new furoquinolinone derivative, 1-(3'-hydroxypropyl)-4,6,8-trimethylfuro[2,3-h]quinolin-2(1H)-one (HPFQ, 4), was prepared, in which the nitrogen atom in position 1 carries a hydroxypropyl chain. The antiproliferative activity of HPFQ was studied in comparison with its analogue 1,4,6,8-tetramethylfuro[2,3-h]quinolin-2(1H)-one (FQ) and 8-methoxypsoralen (8-MOP). By incubation in the dark, HPFQ, although retaining antitopoisomerase II activity, appeared less effective than FQ. Upon UVA irradiation, HPFQ produced little amounts of singlet oxygen, but detectable levels of superoxide anion; like FQ, HPFQ induced numbers of DNA-protein cross-links, but no interstrand cross-links in mammalian cells. The HPFQ phototoxicity was comparable to that of FQ and 8-MOP, while mutagenic activity, scored in two Escherichia coli strains, seemed much less remarkable.


Enzyme Inhibitors/pharmacology , Furocoumarins/pharmacology , Mutagens/pharmacology , Photosensitizing Agents/pharmacology , Topoisomerase II Inhibitors , Cell Division/drug effects , DNA Damage , Enzyme Inhibitors/chemistry , Furocoumarins/chemistry , HeLa Cells , Humans , Molecular Structure , Mutagens/chemistry , Photobiology , Photosensitizing Agents/chemistry
7.
J Med Chem ; 42(15): 2936-45, 1999 Jul 29.
Article En | MEDLINE | ID: mdl-10425103

Some benzopsoralens, carrying a hydroxymethyl or a diethylaminomethyl group at the 3, 5, 8, and 11 positions, were prepared, and their biological activity was compared with that of 4-(hydroxymethyl)benzopsoralen (BP). 5-(Hydroxymethyl)benzopsoralen (7b), 11-(hydroxymethyl)benzopsoralen (7c), and 11-(diethylaminomethyl)benzopsoralen (8c) induced marked antiproliferative effects in mammalian cells by simple incubation in the dark; this activity appeared to be related to their ability to inhibit topoisomerase II. Benzopsoralens appeared to be more active, especially BP and 7c, upon UVA activation. Compounds carrying a methyl group at the 4 position together with a hydroxymethyl or diethylaminomethyl at the 8 position (7d and 8d, respectively) were also effective, although to a lower extent; instead, a substituent at the 3 position canceled all activity. Benzopsoralens did not induce interstrand cross-links in DNA in vitro, as seen in the induction of cytoplasmic <> mutations and double-strand breaks in yeast. This behavior is also compatible with their low mutagenic activity in E. coli WP2 and with the absence of any phototoxicity on the skin. For these features, benzopsoralens seem to be interesting potential drugs for PUVA photochemotherapy and photopheresis. The activity shown in the dark is not sufficient for their possible use as antitumor drugs, but it does offer a new model for the study of topoisomerase inhibitors.


Enzyme Inhibitors/chemical synthesis , Furocoumarins/chemical synthesis , Photosensitizing Agents/chemical synthesis , Animals , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Cross-Linking Reagents/chemical synthesis , Cross-Linking Reagents/chemistry , Cross-Linking Reagents/pharmacology , DNA/chemistry , DNA/radiation effects , DNA Damage/drug effects , DNA, Fungal/drug effects , DNA, Fungal/radiation effects , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Furocoumarins/chemistry , Furocoumarins/pharmacology , Guinea Pigs , Humans , In Vitro Techniques , Methoxsalen/chemistry , Methoxsalen/pharmacology , Mutagenicity Tests , Mutation , Photosensitizing Agents/chemistry , Photosensitizing Agents/pharmacology , Skin/radiation effects , Spectrophotometry, Ultraviolet , Structure-Activity Relationship , Topoisomerase II Inhibitors , Tumor Cells, Cultured , Ultraviolet Rays , Yeasts/drug effects , Yeasts/genetics , Yeasts/radiation effects
8.
Farmaco ; 54(3): 134-44, 1999 Mar 31.
Article En | MEDLINE | ID: mdl-10371025

4,4',5'-Trimethyl-1'-thioangelicin (1) and 4,6,4',5'-tetramethyl-1'-thioangelicin (2), two newly synthesised isosters of furocoumarins having a sulfur atom in their five-membered ring, were studied in terms of interactions with DNA, both in the ground state and after UVA light absorption. The compounds were able to intercalate the macromolecule and to photobind efficiently, forming C4-cycloadducts with thymine. The antiproliferative effect of this binding was shown in Ehrlich and HeLa cells and by T2 phage inactivation. Tests on Salmonella typhimurium indicated low mutagenic activity. In particular, compound 1 has photobiological activity comparable with that of 4,6,4'-trimethylangelicin, but is less mutagenic.


Coumarins/pharmacology , Furocoumarins/pharmacology , Mutagens/pharmacology , Photosensitizing Agents/pharmacology , Thiophenes/pharmacology , Cell Division/drug effects , Cell Division/radiation effects , Coumarins/chemical synthesis , Coumarins/radiation effects , Cross-Linking Reagents , DNA/drug effects , DNA Adducts , Furocoumarins/chemical synthesis , Furocoumarins/radiation effects , HeLa Cells , Humans , Mass Spectrometry , Molecular Structure , Mutagenesis/drug effects , Mutagenesis/radiation effects , Mutagens/chemical synthesis , Mutagens/radiation effects , Myoviridae/drug effects , Myoviridae/genetics , Myoviridae/radiation effects , Photobiology , Photochemistry , Photolysis , Photosensitizing Agents/chemical synthesis , Photosensitizing Agents/radiation effects , Reactive Oxygen Species , Salmonella typhimurium/drug effects , Salmonella typhimurium/genetics , Salmonella typhimurium/radiation effects , Thiophenes/chemical synthesis , Thiophenes/radiation effects
9.
Farmaco ; 53(6): 431-7, 1998 Jun 30.
Article En | MEDLINE | ID: mdl-9764477

A series of methyl and ethyl quaternary pyridiniumtetrahydrocarbazoles was synthesized and studied in comparison with ellipticine, chosen as a reference. In general, their antiproliferative activity, tested in different biological substrates, appeared to be higher than that of the corresponding non-quaternarized compounds. This fact could be attributed to the introduction of a positive charge in the molecule, which can stabilize the molecular complex they form with DNA. In a prokaryotic system, the T2 bacteriophage, both quaternarized and non-quaternarized compounds inhibited its infectivity moderately, in a similar way to ellipticine. This effect seemed to be connected to a direct activity on the virions rather than on the indicator bacteria. In mammalian cells, the pyridiniumtetrahydrocarbazoles were more effective. In particular, they appeared to be very active in inhibiting DNA synthesis in Ehrlich ascites cells; some of them were as effective as ellipticine. However, pyridiniumtetrahydrocarbazoles were less active in comparison with ellipticine when their capacity for inhibiting the clonal growth in Chinese hamster ovary (CHO) cells was tested. A similar picture was obtained studying the formation of chromosome aberrations and of sister chromatid exchanges in the same cells. These different responses can be explained considering that the data on DNA synthesis reflect effects only on DNA replication within a short time, without considering any later consequences; on the contrary, in the long-term tests, other events, which lead to cell killing or genotoxicity, can take place. Pyridiniumtetrahydrocarbazoles damage DNA, inducing double-strand breaks efficiently. These observations, together with the data already obtained on unsubstituted derivatives, suggest the pyridiniumtetrahydrocarbazoles induce antiproliferative and genotoxic effects, very probably by inhibiting topoisomerase II.


Carbazoles/chemical synthesis , Animals , Bacteriophages/drug effects , CHO Cells , Carbazoles/pharmacology , Cell Survival , Chromosome Aberrations , Cricetinae , DNA Damage , DNA Replication/drug effects , Sister Chromatid Exchange , Spectrum Analysis , Tumor Cells, Cultured
10.
Photochem Photobiol ; 68(2): 157-63, 1998 Aug.
Article En | MEDLINE | ID: mdl-9723209

Some photobiological properties of 1'-thieno-4,6,4'-trimethylangelicin (TTMA), a new isoster of 4,6,4'-trimethylangelicin (TMA) were studied in comparison with the parent compound. The TTMA absorbs UVA light and photobinds in vitro to DNA more efficiently than TMA; however, in Ehrlich cells in vivo TTMA linked to DNA to a lesser extent than the parent compound. In general, the formation of damage into DNA is in line with this last result: In fact, TTMA and TMA form equivalent amounts of interstrand cross-links (ISC) both in vitro in linearized PM2 DNA and in vivo in HeLa cells. In this system TTMA induces DNA-protein cross-links (DPC) more efficiently than TMA; on the contrary, no significant amounts of single-strand breaks were detected with both compounds. The antiproliferative activity of TTMA is consistent with these results, being only slightly more pronounced than that of TMA. Experiments carried out using double irradiation demonstrated that these drugs are capable of inducing antiproliferative effects by biphotonic reactions, including the formation of both ISC and DPC. Thus, replacement of the oxygen atom by a sulfur increases the UV absorption of the drug and its capacity to photobind to DNA in vitro but does not yield a comparable enhancement of its photosensitizing properties in vivo; this might be due to various reasons, for instance to an increase in the lipophilic character that could modify the behavior in vivo.


Furocoumarins/pharmacology , Photosensitizing Agents/pharmacology , Animals , Carcinoma, Ehrlich Tumor/drug therapy , Cell Division/drug effects , DNA Damage , HeLa Cells , Humans , Mice , Photochemotherapy , Tumor Cells, Cultured
11.
Farmaco ; 53(8-9): 602-10, 1998.
Article En | MEDLINE | ID: mdl-10081825

A series of angelicin heteroanalogues, in which the furan was replaced by thiophene or a 1-substituted pyrazole moiety, was synthesised in order to obtain potential therapeutic agents with antiproliferative and/or other biological activities. In general, the antiproliferative activity of the new thioangelicin, tested in different biological substrates, appeared to be higher than that of the angelicin, the natural parent compound, but lower than that of 8-MOP, the furocoumarin ordinarily used in PUVA therapy and photopheresis. Thioangelicin 6 induced strong inhibition of T2 bacteriophage infectivity and was able to significantly repress the DNA synthesis in Ehrlich ascites cells and the clonal growth in HeLa cells. The pyrazolocoumarins did not show any noticeable effect upon UVA irradiation in all the biological systems considered. All the new angelicin heteroanalogues appeared to be free of the known phototoxicity of furocoumarins on the skin. The pyrazolocoumarins have also been tested as anti-inflammatory, analgesic, antipyretic, local anaesthetic, anti-arrhythmic and platelet anti-aggregating agents by standard procedures. In this class of derivatives, 10a showed good anti-inflammatory and antipyretic properties, while 9a and 11a showed significant local anaesthetic activity.


Furocoumarins/chemistry , Furocoumarins/pharmacology , Photosensitizing Agents/chemistry , Photosensitizing Agents/pharmacology , Animals , Anti-Arrhythmia Agents/chemical synthesis , Anti-Arrhythmia Agents/chemistry , Anti-Arrhythmia Agents/pharmacology , Cell Division/drug effects , DNA Replication/drug effects , DNA, Neoplasm/biosynthesis , Furocoumarins/chemical synthesis , Guinea Pigs , Magnetic Resonance Spectroscopy , Molecular Structure , Myoviridae/drug effects , Photosensitizing Agents/chemical synthesis , Platelet Aggregation Inhibitors/chemical synthesis , Platelet Aggregation Inhibitors/chemistry , Platelet Aggregation Inhibitors/pharmacology , Skin/drug effects , Skin/radiation effects , Tumor Cells, Cultured , Ultraviolet Rays
12.
Farmaco ; 52(1): 7-12, 1997 Jan.
Article En | MEDLINE | ID: mdl-9181674

The synthesis of 2H-benzopyrano[7,8-b][1,4]tetrahydrobenzodioxin-2-ones and 2H-benzopyrano [7,8-b][1,4]benzodioxin-2-ones is reported. This class of compounds, prepared with the aim of obtaining new monofunctional photosensitizing drug, appears to be ineffective upon UVA irradiation but shows a moderate but significant activity in the dark.


Antineoplastic Agents/chemical synthesis , Benzopyrans/chemical synthesis , Dioxins/chemical synthesis , Photosensitizing Agents/chemical synthesis , Animals , Antineoplastic Agents/pharmacology , Benzopyrans/pharmacology , Carcinoma, Ehrlich Tumor/drug therapy , DNA, Neoplasm/biosynthesis , Dioxins/pharmacology , HeLa Cells , Humans , Photosensitizing Agents/pharmacology , T-Phages/drug effects , Tumor Cells, Cultured , Ultraviolet Rays
13.
J Photochem Photobiol B ; 40(3): 299-304, 1997 Oct.
Article En | MEDLINE | ID: mdl-9372620

The capacity of 2,6-dimethyl-9-methoxy-4H-pyrrolo [3,2,1-ij] quinolin-4-one (PQ), a furocoumarin analogue, of inhibiting protein synthesis in Ehrlich cells upon UVA irradiation was investigated. Using 8-methoxypsoralen (8-MOP) as a reference, we observed that in our short-term test the block of RNA synthesis do not affect protein synthesis, which is driven by pre-synthesised molecules of m-RNA; actually 8-MOP, studied at 100 microM concentration, practically abolished RNA synthesis without affecting significantly protein synthesis. Studying PQ sensitization in HL60 cells by alkaline elution and protein precipitation, the formation of covalent RNA-protein cross-links was observed. 8-MOP, assayed in severe experimental conditions, induced only moderate amounts of such lesion. On the basis of the data obtained in experiments carried out using various scavengers or exposing cells to UVA light in a nitrogen atmosphere, this damage appeared to be due to singlet oxygen formation, which is generated by PQ to a large extent. These results are consistent with the data obtained by H. Singh and J.A. Vadasz (Singlet oxygen: a major reactive species in the furocoumarin photosensitized inactivation of E.coli ribosomes, Photochem. Photobiol., 28 (1978) 539-545) on E.coli ribosomes. The lower activity we observed with 8-MOP might be attributed to a different sensitivity of whole mammalian cells in comparison with isolated ribosomes.


Cross-Linking Reagents/pharmacology , Photosensitizing Agents/pharmacology , Protein Synthesis Inhibitors/pharmacology , Proteins/metabolism , Pyrroles/pharmacology , Quinolones/pharmacology , RNA/metabolism , HL-60 Cells , Humans , Nitrogen , Oxygen , Protein Biosynthesis , RNA/biosynthesis , Ultraviolet Rays
14.
J Photochem Photobiol B ; 34(2-3): 159-68, 1996 Jul.
Article En | MEDLINE | ID: mdl-8810533

1,4,6,8-tetramethyl-2H-furo[2,3-h]quinolin-2-one (FQ) is a new isoster of angelicin characterised by an extremely strong photosensitizing activity, which is several times higher than that of 8-MOP and 4,6,4'-trimethylangelicin (TMA). Following treatment with 1.2 microM FQ and a dose as low as 0.05 kJ m(-2) of UVA irradiation, survival (colony forming ability) of HeLa cells was abolished, while TMA and 8-MOP (even at five times the concentration for the latter) were practically ineffective. Upon UVA irradiation FQ induces various types of lesions in mammalian cells in DNA: single-strand breaks (SSBs), many monoadducts and covalent DNA-protein cross-links (DPC), but not interstrand cross-links (ISC). Using the two step irradiation procedure, DPC induced by FQ appeared to be severe lesions, having a high antiproliferative activity; their formation requires the successive absorption of two photons, thus, in this respect, resembling ISC formation. In spite of its higher capacity for damaging DNA, FQ showed a skin-phototoxicity potency very similar to 8-MOP. As some benzopsoralens, FQ induced a certain antiproliferative activity also in the dark, which was accompanied by the formation of double-strand breaks into DNA associated with DPC. This lesion is generally induced by topoisomerase inhibitors. On the basis of these features, FQ can be expected to show useful activities in photochemotherapy and photopheresis. However, before medical use careful studies on its genotoxicity are required.


Photosensitizing Agents/pharmacology , Quinolones/pharmacology , Animals , Carcinoma, Ehrlich Tumor , Cell Division , Cross-Linking Reagents , DNA/biosynthesis , DNA/drug effects , DNA/radiation effects , DNA Damage , Furocoumarins/chemistry , Furocoumarins/pharmacology , Guinea Pigs , HL-60 Cells , HeLa Cells , Humans , Methoxsalen/chemistry , Methoxsalen/pharmacology , Photochemistry , Photosensitizing Agents/chemistry , Quinolones/chemistry , Spectrophotometry , Ultraviolet Rays
15.
J Med Chem ; 39(6): 1293-302, 1996 Mar 15.
Article En | MEDLINE | ID: mdl-8632436

With the aim of obtaining new potential photochemotherapeutic agents, having increased antiproliferative activity and decreased undesired effects, we have prepared some new furoquinolinones. Two of them have been studied in detail: 1,4,6,8-tetramethyl-2H-furo[2,3-h]-quinolin-2-one (8), and 4,6,8,9-tetramethyl-2H-furo[2,3-h]quinolin-2-one (10). These compounds form a molecular complex with DNA, undergoing intercalation inside the duplex macromolecule, as shown by linear flow dichroism. The complexed ligands, by subsequent irradiation with UV-A light, photobind with the macromolecule forming only monocycloadducts with thymine with cis-syn configuration. In order to evaluate the electronic effects induced by the nitrogen atom in position 1 of 8, semiempirical calculations have been performed on both 4,6,4'-trimethylangelicin (TMA) and 8. The results obtained do not clearly differentiate between the two molecules which, at this level of approximation, show the possibility of photoreaction with both the 3,4- and 8,9-olefinic bonds for 8 and the 3,4- and 4',5'-bonds for TMA. In the lower energy conformation of intercalated 8, the furan ring is turned toward the minor groove of the polynucleotide, in such a way that photoreaction of this ring with thymine is favored. These compounds unexpectedly inhibit DNA and RNA synthesis in Ehrlich cells, in the dark. They also show a strong photoantiproliferative activity, 2 orders of magnitude higher than 8-methoxypsoralen (8-MOP), the most used drug for photochemotherapy. Their mutagenic activity on Escherichia coli is similar to that of TMA and 8-MOP. On the basis of these results, the compounds should deserve evaluation of their activity in the treatment of hyperproliferative skin diseases.


Furocoumarins/chemical synthesis , Photochemotherapy , Skin Diseases/drug therapy , DNA/metabolism , Furocoumarins/pharmacology , Furocoumarins/toxicity , Mutagens/toxicity , Myoviridae/drug effects , RNA/biosynthesis
16.
Farmaco ; 50(10): 669-78, 1995 Oct.
Article En | MEDLINE | ID: mdl-8590574

Convenient synthesis of 3-acyl-2H-furo[2,3-h]-1-benzopyran-2-ones, esters of 2-oxo-2H-furo[2,3-h]-1-benzopyran-3-carboxylic acid and 2H-furo[2,3-h]-1-benzopyran-3-carboxamides was accomplished via aromatization of the adducts obtained by a reaction between (E)-5-dimethyl-aminomethylene-6,7-dihydrobenzofuran-4(5H)-one and the appropriate acylacetate or dialkyl malonate. These compounds are angelicin derivatives which were prepared with the aim of obtaining intrinsically monofunctional drugs for photochemotherapy, with only one photoreactive site in their molecule. The new angelicins appear to be free of the known phototoxicity of furocoumarins on the skin and at a genetic level. The 3-carboxylic esters showed significant antiproliferative activity in Ehrlich ascites cells and T2 bacteriophage; the other derivatives were only slightly effective. The features of these compounds are such that they represent a new model for non-toxic agents for photochemotherapy.


Furocoumarins/chemical synthesis , Photosensitizing Agents/chemical synthesis , Animals , Carcinoma, Ehrlich Tumor/pathology , Cell Division/drug effects , Chemical Phenomena , Chemistry, Physical , DNA, Neoplasm/biosynthesis , Escherichia coli/drug effects , Escherichia coli/genetics , Furocoumarins/chemistry , Furocoumarins/pharmacology , Guinea Pigs , Mutagens/toxicity , Oxygen/chemistry , Photochemistry , Photosensitizing Agents/chemistry , Photosensitizing Agents/pharmacology , Singlet Oxygen , T-Phages/drug effects , Ultraviolet Rays
17.
Farmaco ; 50(2): 91-8, 1995 Feb.
Article En | MEDLINE | ID: mdl-7766281

With the aim of obtaining further knowledge on the antiproliferative activity of pyrroloquinolines and isoquinolines, we prepared four unsubstituted angular pyridotetrahydrocarbazoles having a fourth non-aromatic ring, via modified Fischer synthesis. These compounds may be considered as simpler analogues of ellipticine. They induced evident antiproliferative effects in Ehrlich ascites and in CHO cells in vitro, but were ineffective on T2 bacteriophage. These compounds formed molecular complexes with DNA in vitro, while in CHO cells in vivo, they induced double-strand breaks in DNA and DNA-protein cross-links. These data suggest that these ellipticine analogoues are capable of inhibiting topoisomerase II, as the parent compound does. The most active derivative was 2N-5H-6,7,8,9-tetrahydropyrido[2,3-a]carbazole, which represents an interesting model for the study of new antitumor drugs.


Cell Division/drug effects , Ellipticines/pharmacology , Intercalating Agents/pharmacology , Animals , Antiviral Agents/chemical synthesis , Antiviral Agents/chemistry , Antiviral Agents/pharmacology , CHO Cells , Carcinoma, Ehrlich Tumor/drug therapy , Circular Dichroism , Cricetinae , DNA/drug effects , Ellipticines/chemical synthesis , Ellipticines/chemistry , Intercalating Agents/chemistry , Mice , Myoviridae/drug effects , Structure-Activity Relationship
18.
Mutat Res ; 311(2): 277-85, 1994 Dec 01.
Article En | MEDLINE | ID: mdl-7526193

The ability of 4-hydroxymethyl-4',5'-benzopsoralen (HMBP) to damage DNA of Chinese hamster ovary cells (CHO) and to inhibit the activity of topoisomerase II in vitro has been studied. This compound is characterized by a fourth ring condensed at the furan-side in the psoralen molecule. Contrary to other known furocoumarin derivatives, HMBP induces chromosomal aberrations in mammalian cells without UVA activation. The lesions induced in the dark by HMBP in DNA were studied by alkaline and neutral elution in CHO cells; comparable amounts of single-strand breaks and DNA-protein cross-links as well as the formation of double-strand breaks were detected. Moreover, HMBP appeared to inhibit the activity of mammalian topoisomerase II in vitro, in both the catenation and the decatenation assay. In these experiments the drug was effective only when it was pre-incubated with DNA substrate. These results are also consistent with the cytotoxic and mutagenic activity of HMBP in the dark, as tested on V79 Chinese hamster cells (V79/HGPRT system).


DNA Adducts , DNA Damage , Furocoumarins , Furocoumarins/toxicity , Mutagens/toxicity , Topoisomerase II Inhibitors , Animals , CHO Cells/drug effects , CHO Cells/enzymology , Cricetinae , Cricetulus , Cross-Linking Reagents , Darkness , Furocoumarins/chemistry , Mutagenicity Tests , Regression Analysis
19.
J Photochem Photobiol B ; 26(2): 197-201, 1994 Nov.
Article En | MEDLINE | ID: mdl-7815193

4,6,4'-Trimethylangelicin, a well-known effective photosensitizer described as a pure monofunctional reactant with DNA, can induce interstrand cross-links in mammalian cell DNA in vivo (about 15% relative to 8-methoxypsoralen), as observed using alkaline elution and Chinese hamster ovary cells. Experiments performed using the two-step irradiation method and HeLa cells support these data. In contrast with 4,6,4'-trimethylangelicin, 4'-methylangelicin and 4,4'-dimethylangelicin do not form interstrand cross-links. These results are consistent with those recently reported by Chen et al. (X. Chen, J. Kagan, F. Dall'Acqua, D. Averbeck and E. Bisagni, J. Photochem. Photobiol. B: Biol, 22 (1994) 51-57) using pBR322 and M13 DNA. The cross-linking ability of 4,6,4'-trimethylangelicin does not seem to be related to a particular feature of these DNAs but to the compound itself.


DNA/drug effects , Furocoumarins/pharmacology , Photosensitizing Agents/pharmacology , Ultraviolet Rays , Animals , CHO Cells , Cricetinae , DNA/radiation effects , Dose-Response Relationship, Radiation , HeLa Cells , Humans , Photochemotherapy
20.
Farmaco ; 49(10): 607-14, 1994 Oct.
Article En | MEDLINE | ID: mdl-7530010

Searching new photochemotherapeutic agents, a series of methylpirroloquinolinones were prepared by a new synthetic pathway, thus univocally obtaining the title compounds. The photobiological activity of some of these compounds was assayed; upon UVA activation, a marked capacity of inhibiting macromolecular synthesis in Ehrlich cells was observed, which appeared to be markedly high testing protein synthesis. Pyrroloquinolinones induced a strong inhibition of the clonal growing capacity of HeLa cells cultivated in vitro. Studying DNA photodamage in HL60 cells high amounts of single strand breaks and DNA-protein cross-links were detected. Pyrroloquinolines inhibited T2 bacteriophage infectivity, but induced no significant amounts of revertants in E. coli WP2 TM9, a strain very sensitive to DNA damage. On the contrary, 8-MOP, tested in the same experimental conditions exhibited an evident photomutagenecity. These data suggest that pyrroloquinolines induced antiproliferative effects by a mechanism in which DNA-photobinding practically does not takes place, and therefore different from that shown by known furocoumarins. Pyrroloquinolinones showed also a moderate antiproliferative activity in the dark.


Furocoumarins/chemical synthesis , Photochemotherapy , Photosensitizing Agents/chemical synthesis , Quinolones/chemical synthesis , Cell Division/drug effects , DNA/biosynthesis , DNA Damage , Furocoumarins/pharmacology , HeLa Cells , Humans , Photosensitizing Agents/pharmacology , Quinolones/pharmacology , RNA/biosynthesis
...